These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 25987089

  • 21. Retinoblastoma protein-interacting zinc-finger gene 1 (RIZ1) dysregulation in human malignant meningiomas.
    Liu ZY, Wang JY, Liu HH, Ma XM, Wang CL, Zhang XP, Tao YQ, Lu YC, Liao JC, Hu GH.
    Oncogene; 2013 Mar 07; 32(10):1216-22. PubMed ID: 22614009
    [Abstract] [Full Text] [Related]

  • 22. Biallelic inactivation of the RIZ1 gene in human gastric cancer.
    Tokumaru Y, Nomoto S, Jerónimo C, Henrique R, Harden S, Trink B, Sidransky D.
    Oncogene; 2003 Oct 09; 22(44):6954-8. PubMed ID: 14534544
    [Abstract] [Full Text] [Related]

  • 23. Epigenetic inactivation of HOXA11, a novel functional tumor suppressor for renal cell carcinoma, is associated with RCC TNM classification.
    Wang L, Cui Y, Sheng J, Yang Y, Kuang G, Fan Y, Jin J, Zhang Q.
    Oncotarget; 2017 Mar 28; 8(13):21861-21870. PubMed ID: 28423531
    [Abstract] [Full Text] [Related]

  • 24. OSR1 is a novel epigenetic silenced tumor suppressor regulating invasion and proliferation in renal cell carcinoma.
    Zhang Y, Yuan Y, Liang P, Guo X, Ying Y, Shu XS, Gao M, Cheng Y.
    Oncotarget; 2017 May 02; 8(18):30008-30018. PubMed ID: 28404905
    [Abstract] [Full Text] [Related]

  • 25. Frequent epigenetic suppression of tumor suppressor gene glutathione peroxidase 3 by promoter hypermethylation and its clinical implication in clear cell renal cell carcinoma.
    Liu Q, Jin J, Ying J, Sun M, Cui Y, Zhang L, Xu B, Fan Y, Zhang Q.
    Int J Mol Sci; 2015 May 11; 16(5):10636-49. PubMed ID: 25970749
    [Abstract] [Full Text] [Related]

  • 26. Methylation-associated silencing of TU3A in human cancers.
    Awakura Y, Nakamura E, Ito N, Kamoto T, Ogawa O.
    Int J Oncol; 2008 Oct 11; 33(4):893-9. PubMed ID: 18813805
    [Abstract] [Full Text] [Related]

  • 27. Aberrant promoter hypermethylation of PBRM1, BAP1, SETD2, KDM6A and other chromatin-modifying genes is absent or rare in clear cell RCC.
    Ibragimova I, Maradeo ME, Dulaimi E, Cairns P.
    Epigenetics; 2013 May 11; 8(5):486-93. PubMed ID: 23644518
    [Abstract] [Full Text] [Related]

  • 28. Retinoblastoma protein-interacting zinc finger 1 (RIZ1) regulates the proliferation of monocytic leukemia cells via activation of p53.
    Shadat NM, Koide N, Khuda II, Dagvadorj J, Tumurkhuu G, Naiki Y, Komatsu T, Yoshida T, Yokochi T.
    Cancer Invest; 2010 Oct 11; 28(8):806-12. PubMed ID: 20594067
    [Abstract] [Full Text] [Related]

  • 29. RIZ1 and histone methylation status in pituitary adenomas.
    Xue Y, Chen R, Du W, Yang F, Wei X.
    Tumour Biol; 2017 Jul 11; 39(7):1010428317711794. PubMed ID: 28718376
    [Abstract] [Full Text] [Related]

  • 30. Aberrant methylation of the RIZ1 gene in myelodysplastic syndrome and acute myeloid leukemia.
    Mori N, Yoshinaga K, Tomita K, Ohwashi M, Kondoh T, Shimura H, Wang YH, Shiseki M, Okada M, Motoji T.
    Leuk Res; 2011 Apr 11; 35(4):516-21. PubMed ID: 20828818
    [Abstract] [Full Text] [Related]

  • 31. Deletions and altered expression of the RIZ1 tumour suppressor gene in 1p36 in pheochromocytomas and abdominal paragangliomas.
    Geli J, Nord B, Frisk T, Edström Elder E, Ekström TJ, Carling T, Bäckdahl M, Larsson C.
    Int J Oncol; 2005 May 11; 26(5):1385-91. PubMed ID: 15809732
    [Abstract] [Full Text] [Related]

  • 32. Contribution of RIZ1 to regulation of proliferation and migration of a liver fluke-related cholangiocarcinoma cell.
    Khaenam P, Niibori A, Okada S, Jearanaikoon P, Araki N, Limpaiboon T.
    Asian Pac J Cancer Prev; 2012 May 11; 13(8):4007-11. PubMed ID: 23098508
    [Abstract] [Full Text] [Related]

  • 33. Alteration in gene expression profile and oncogenicity of esophageal squamous cell carcinoma by RIZ1 upregulation.
    Dong SW, Li D, Xu C, Sun P, Wang YG, Zhang P.
    World J Gastroenterol; 2013 Oct 07; 19(37):6170-7. PubMed ID: 24115813
    [Abstract] [Full Text] [Related]

  • 34. Loss of HNF1alpha function in human renal cell carcinoma: frequent mutations in the VHL gene but not the HNF1alpha gene.
    Lemm I, Lingott A, Pogge v Strandmann E, Zoidl C, Bulman MP, Hattersley AT, Schulz WA, Ebert T, Ryffel GU.
    Mol Carcinog; 1999 Apr 07; 24(4):305-14. PubMed ID: 10326868
    [Abstract] [Full Text] [Related]

  • 35. Promoter hypermethylation profile of kidney cancer with new proapoptotic p53 target genes and clinical implications.
    Christoph F, Weikert S, Kempkensteffen C, Krause H, Schostak M, Köllermann J, Miller K, Schrader M.
    Clin Cancer Res; 2006 Sep 01; 12(17):5040-6. PubMed ID: 16951219
    [Abstract] [Full Text] [Related]

  • 36. Identification of novel target genes by an epigenetic reactivation screen of renal cancer.
    Ibanez de Caceres I, Dulaimi E, Hoffman AM, Al-Saleem T, Uzzo RG, Cairns P.
    Cancer Res; 2006 May 15; 66(10):5021-8. PubMed ID: 16707423
    [Abstract] [Full Text] [Related]

  • 37. Classic SRY-box protein SOX7 functions as a tumor suppressor regulating WNT signaling and is methylated in renal cell carcinoma.
    Wang L, Fan Y, Zhang L, Li L, Kuang G, Luo C, Li C, Xiang T, Tao Q, Zhang Q, Ying J.
    FASEB J; 2019 Jan 15; 33(1):254-263. PubMed ID: 29957056
    [Abstract] [Full Text] [Related]

  • 38. Functional and epigenetic characterization of the KRT19 gene in renal cell neoplasms.
    Paiva F, Duarte-Pereira S, Costa VL, Ramalho-Carvalho J, Patrício P, Ribeiro FR, Lobo F, Oliveira J, Jerónimo C, Henrique R.
    DNA Cell Biol; 2011 Feb 15; 30(2):85-90. PubMed ID: 20874491
    [Abstract] [Full Text] [Related]

  • 39. HBx represses RIZ1 expression by DNA methyltransferase 1 involvement in decreased miR-152 in hepatocellular carcinoma.
    Zhao Z, Hu Y, Shen X, Lao Y, Zhang L, Qiu X, Hu J, Gong P, Cui H, Lu S, Zheng Y, Zhou M, Fan H.
    Oncol Rep; 2017 May 15; 37(5):2811-2818. PubMed ID: 28339081
    [Abstract] [Full Text] [Related]

  • 40. BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer.
    Majid S, Dar AA, Ahmad AE, Hirata H, Kawakami K, Shahryari V, Saini S, Tanaka Y, Dahiya AV, Khatri G, Dahiya R.
    Carcinogenesis; 2009 Apr 15; 30(4):662-70. PubMed ID: 19221000
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.